{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:04:51Z","timestamp":1785769491597,"version":"3.56.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.seminoncol.2026.152500","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:26:53Z","timestamp":1776011213000},"page":"152500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of natural triterpenoids in pancreatic cancer"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-5897","authenticated-orcid":false,"given":"Chengu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Patrick I","family":"Okolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8013","key":"10.1016\/j.seminoncol.2026.152500_bib0001","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41586-024-07379-z","article-title":"Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"629","author":"Wasko","year":"2024","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.seminoncol.2026.152500_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.09.024","article-title":"Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer","volume":"187","author":"You","year":"2024","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152500_bib0003","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/s41591-024-03075-7","article-title":"Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer","volume":"30","author":"Bojmar","year":"2024","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152500_bib0004","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1097\/MPA.0000000000002359","article-title":"The population-level prevalence of exocrine pancreas insufficiency and the subsequent risk of pancreatic cancer","volume":"53","author":"Babajide","year":"2024","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79342-x","article-title":"Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival","volume":"14","author":"\u00c7orbac\u0131","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217515","article-title":"Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer","volume":"613","author":"Yuan","year":"2025","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152500_bib0007","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.21873\/anticanres.17348","article-title":"A novel oncolytic viral therapy using coxsackievirus B3 (CVB3) for human pancreatic cancer including cancer-associated fibroblasts","volume":"44","author":"Ogata","year":"2024","journal-title":"Anticancer Res"},{"issue":"21","key":"10.1016\/j.seminoncol.2026.152500_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70388","article-title":"Predicting pancreatic cancer in new-onset diabetes cohort using a novel model with integrated clinical and genetic indicators: a large-scale prospective cohort study","volume":"13","author":"Sun","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-024-03201-w","article-title":"CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment","volume":"43","author":"Tao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0010","article-title":"Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis","volume":"12","author":"Wang","year":"2024","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152500_bib0011","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14740338.2024.2396387","article-title":"Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis","volume":"24","author":"Li","year":"2025","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152500_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18209","article-title":"Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"11","key":"10.1016\/j.seminoncol.2026.152500_bib0013","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152500_bib0014","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.7150\/jca.107359","article-title":"Factors affecting delayed recovery from neutropenia in patients with pancreatic cancer receiving gemcitabine plus nab-paclitaxel","volume":"16","author":"Yoshida","year":"2025","journal-title":"J Cancer"},{"issue":"12","key":"10.1016\/j.seminoncol.2026.152500_bib0015","doi-asserted-by":"crossref","first-page":"e7345","DOI":"10.1002\/cam4.7345","article-title":"Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment","volume":"13","author":"Giordano","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0016","first-page":"1","article-title":"A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3)","volume":"12","author":"Wainberg","year":"2025","journal-title":"Future Oncol"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0017","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/jcm14041129","article-title":"Current and emerging treatment options for pancreatic cancer: a comprehensive review","volume":"14","author":"Hayat","year":"2025","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152500_bib0018","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1097\/MS9.0000000000002011","article-title":"Pancreatic cancer: from early detection to personalized treatment approaches","volume":"86","author":"Khayat","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0019","doi-asserted-by":"crossref","first-page":"oyae200","DOI":"10.1093\/oncolo\/oyae200","article-title":"Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer","volume":"30","author":"Runcie","year":"2025","journal-title":"Oncologist"},{"issue":"6728","key":"10.1016\/j.seminoncol.2026.152500_bib0020","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.ado3409","article-title":"A scaffold protein manages the biosynthesis of steroidal defense metabolites in plants","volume":"386","author":"Boccia","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0021","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/jox14040084","article-title":"Oxidative processes and xenobiotic metabolism in plants: mechanisms of defense and potential therapeutic implications","volume":"14","author":"Vicidomini","year":"2024","journal-title":"J Xenobiot"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152500_bib0022","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/CEJ.0000000000000171","article-title":"Consumption of fruit and vegetables reduces risk of pancreatic cancer: evidence from epidemiological studies","volume":"25","author":"Wu","year":"2016","journal-title":"Eur J Cancer Prev"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0023","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00394-024-03472-1","article-title":"Cruciferous vegetables intake reduces pancreatic cancer risk: an updated systematic review with meta-analysis","volume":"63","author":"Zhang","year":"2024","journal-title":"Eur J Nutr"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152500_bib0024","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1039\/D4RA06721E","article-title":"Drimane-type sesquiterpenoids and triterpenoids from the whole plant of Limonium sinense with their antiproliferative and anti-inflammatory activities","volume":"15","author":"Qi","year":"2025","journal-title":"RSC Adv"},{"issue":"13","key":"10.1016\/j.seminoncol.2026.152500_bib0025","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2174\/0118715206336591241112061246","article-title":"In-silico and in-vitro molecular analysis of oleanolic acid and cisplatin on pancreatic cancer (Panc-1 Cell Line)","volume":"25","author":"Jegannathan","year":"2025","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/0113895575293138240527061556","article-title":"Nimbolide: a potential phytochemical agent in multimodal pancreatic cancer therapies","volume":"25","author":"Jogi","year":"2025","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152500_bib0027","first-page":"262","article-title":"Ursolic acid restores sensitivity to gemcitabine through the RAGE\/NF-\u03bab\/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model","volume":"29","author":"Li","year":"2021","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/809714","article-title":"A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors","volume":"2015","author":"Qian","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152500_bib0029","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11523-024-01088-3","article-title":"Identifying actionable alterations in KRAS wild-type pancreatic cancer","volume":"19","author":"Elhariri","year":"2024","journal-title":"Target Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40364-024-00721-7","article-title":"Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer","volume":"13","author":"Niu","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105658","article-title":"Bruceine A induces cell growth inhibition and apoptosis through PFKFB4\/GSK3\u03b2 signaling in pancreatic cancer","volume":"169","author":"Zhang","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152500_bib0032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12539-016-0182-7","article-title":"Ganoderic acid A targeting \u03b2-catenin in wnt signaling pathway: in silico and in vitro study","volume":"10","author":"Gill","year":"2018","journal-title":"Interdiscip Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0033","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/jgo-20-533","article-title":"Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK","volume":"12","author":"He","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0034","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.7150\/jca.65875","article-title":"Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2\/STAT3 signalling pathway in vivo and in vitro","volume":"13","author":"Xu","year":"2022","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152500_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mmr.2024.13200","article-title":"IFN\u2011\u03b3 induces apoptosis in gemcitabine\u2011resistant pancreatic cancer cells","volume":"29","author":"Kong","year":"2024","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101143","article-title":"Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer","volume":"62","author":"Steen","year":"2025","journal-title":"Neoplasia"},{"issue":"21","key":"10.1016\/j.seminoncol.2026.152500_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38427","article-title":"LINC01857 promotes cell proliferation and migration while dampening cell apoptosis in pancreatic cancer by upregulating CDC42EP3 via miR-450b-5p","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0038","article-title":"Newcastle disease virus harboring the PTEN gene inhibits pancreatic cancer growth by inhibiting PI3K\/AKT\/mTOR signaling and activating apoptosis","volume":"32","author":"Kim","year":"2024","journal-title":"Mol Ther Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0039","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12672-023-00838-5","article-title":"Celastrol suppresses human pancreatic cancer via m6A-YTHDF3-mediated downregulation of claspin and Bcl-2","volume":"14","author":"Zhou","year":"2023","journal-title":"Discov Oncol"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.tiv.2011.02.006","article-title":"Apoptosis mediated cytotoxicity of citrus obacunone in human pancreatic cancer cells","volume":"25","author":"Chidambara Murthy","year":"2011","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122270","article-title":"Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0042","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00432-009-0698-x","article-title":"Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling","volume":"136","author":"Sun","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6571674","article-title":"Cucurbitacin D induces G2\/M phase arrest and apoptosis via the ROS\/p38 pathway in Capan-1 pancreatic cancer cell line","volume":"2020","author":"Kim","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"10.1016\/j.seminoncol.2026.152500_bib0044","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-08-2917","article-title":"Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells","volume":"69","author":"Murtaza","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152500_bib0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/or.2013.2517","article-title":"SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells","volume":"30","author":"Son","year":"2013","journal-title":"Oncol Rep"},{"issue":"19","key":"10.1016\/j.seminoncol.2026.152500_bib0046","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.18632\/aging.203575","article-title":"Inhibition of JAK2\/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer","volume":"13","author":"Fan","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156298","article-title":"Taraxasterol regulates p53 transcriptional activity to inhibit pancreatic cancer by inducing MDM2 ubiquitination degradation","volume":"136","author":"Han","year":"2025","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0048","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389201023666220610113514","article-title":"Saikosaponin-A exhibits antipancreatic cancer activity by targeting the EGFR\/PI3K\/akt pathway","volume":"24","author":"Shi","year":"2023","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155523","article-title":"The paradox of autophagy in cancer: NEAT1\u2032s role in tumorigenesis and therapeutic resistance","volume":"262","author":"Almujri","year":"2024","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0051","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41418-024-01310-9","article-title":"HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer","volume":"31","author":"Ferretti","year":"2024","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108105","article-title":"ENDOLUNG trial, part II. A phase II study of the akt\/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel\/carboplatin in patients with squamous non-small cell lung cancer","volume":"201","author":"Bosch-Barrera","year":"2025","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.seminoncol.2026.152500_bib0053","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/ijc.31211","article-title":"Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways","volume":"142","author":"Wang","year":"2018","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0054","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/ptr.6064","article-title":"Maslinic acid induces autophagy by down-regulating HSPA8 in pancreatic cancer cells","volume":"32","author":"Tian","year":"2018","journal-title":"Phytother Res"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1519186","article-title":"Case report: a successful case of targeted immunotherapy for locally advanced pancreatic cancer under non-surgical conditions","volume":"15","author":"Bi","year":"2025","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.seminoncol.2026.152500_bib0056","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3390\/jcm13216419","article-title":"Updates in immunotherapy for pancreatic cancer","volume":"13","author":"Chick","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0057","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156028","article-title":"The molecular basis of the immunomodulatory effects of natural products: a comprehensive review","volume":"135","author":"Beigoli","year":"2024","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152500_bib0059","first-page":"462","article-title":"Anti-cancer and immunomodulatory activity of a polyethylene glycol-betulinic acid conjugate on pancreatic cancer cells","volume":"11","author":"Fru","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110579","article-title":"Saikosaponin D modulates the polarization of tumor-associated macrophages by deactivating the PI3K\/AKT\/mTOR pathway in murine models of pancreatic cancer","volume":"122","author":"Xu","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"Pt 3","key":"10.1016\/j.seminoncol.2026.152500_bib0061","article-title":"Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer","volume":"338","author":"Zhou","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1512981","article-title":"SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer","volume":"15","author":"Pan","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0063","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12935-024-03500-4","article-title":"The role of KRT7 in metastasis and prognosis of pancreatic cancer","volume":"24","author":"Xu","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"16","key":"10.1016\/j.seminoncol.2026.152500_bib0064","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-23-3638","article-title":"FBXO32 stimulates protein synthesis to drive pancreatic cancer progression and metastasis","volume":"84","author":"Su","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12672-024-01566-0","article-title":"Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization","volume":"15","author":"Ainiwaer","year":"2024","journal-title":"Discov Oncol"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111939","article-title":"Corosolic acid delivered by exosomes from Eriobotrya japonica decreased pancreatic cancer cell proliferation and invasion by inducing SAT1-mediated ferroptosis","volume":"132","author":"Jin","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0067","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.25966","article-title":"Acetyl-11-keto-\u03b2-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression","volume":"129","author":"Park","year":"2011","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.seminoncol.2026.152500_bib0068","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/or.2021.8006","article-title":"Escin inhibits angiogenesis by suppressing interleukin 8 and vascular endothelial growth factor production by blocking nuclear factor \u03bab activation in pancreatic cancer cell lines","volume":"45","author":"Omi","year":"2021","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.seminoncol.2026.152500_bib0069","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3748\/wjg.v19.i10.1582","article-title":"Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells","volume":"19","author":"Tang","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.seminoncol.2026.152500_bib0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbrc.2017.08.170","article-title":"A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt\/mTOR signaling","volume":"493","author":"Pei","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0071","doi-asserted-by":"crossref","DOI":"10.1038\/srep19819","article-title":"Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition","volume":"6","author":"Subramani","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0072","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.18632\/oncotarget.8055","article-title":"Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway","volume":"8","author":"Subramani","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0073","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3892\/ol.2025.14920","article-title":"A study of the association between Helicobacter pylori infection type and pancreatic cancer risk: a systematic review and meta\u2011analysis","volume":"29","author":"Qin","year":"2025","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.seminoncol.2026.152500_bib0074","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.pan.2024.07.006","article-title":"Early tumor shrinkage as a prognostic predictor in chemotherapy-na\u00efve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: an exploratory analysis of JCOG1407","volume":"24","author":"Tezuka","year":"2024","journal-title":"Pancreatology"},{"issue":"14","key":"10.1016\/j.seminoncol.2026.152500_bib0075","doi-asserted-by":"crossref","first-page":"e7459","DOI":"10.1002\/cam4.7459","article-title":"Adjuvant 5-fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer","volume":"13","author":"Kitago","year":"2024","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.seminoncol.2026.152500_bib0076","first-page":"557","article-title":"In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines","volume":"16","author":"Silva","year":"2018","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0077","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3892\/or.2012.1921","article-title":"Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells","volume":"28","author":"Wei","year":"2012","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.seminoncol.2026.152500_bib0078","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1476-5381.2010.00741.x","article-title":"Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer","volume":"160","author":"Iwanski","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.seminoncol.2026.152500_bib0079","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/MPA.0b013e318249d62e","article-title":"Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer","volume":"41","author":"Ahn","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.seminoncol.2026.152500_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111919","article-title":"Pristimerin synergizes with gemcitabine through abrogating Chk1\/53BP1-mediated DNA repair in pancreatic cancer cells","volume":"147","author":"Jiang","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"10.1016\/j.seminoncol.2026.152500_bib0081","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/ptr.6669","article-title":"Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells","volume":"34","author":"Lin","year":"2020","journal-title":"Phytother Res"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:13:01Z","timestamp":1785766381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775426000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0093775426000473"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152500","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of natural triterpenoids in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152500"}}